Clinical trial
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of…
NCT00464438 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00464438 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bacterial Conjunctivitis |
| Intervention type | Drug |
| Interventions | gatifloxacin, moxifloxacin 0.5% eye drops |
| Enrollment | 171 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 23, 2007 |
| Last update posted | Sep 21, 2011 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: